PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 6619: Inhibition of PLK4 overcomes radioresistance in locally advanced rectal cancer through genomic instability and apoptotic cell death.

View Full Paper
SBSungUk BaeJHJeong-Woo HwangHLHyewon Lee

Key Points

  • To determine if inhibition of PLK4 can enhance radiosensitivity in colorectal cancer cells.
  • Treated CRC cell lines HCT116 and HT29 with PLK4 inhibitor CFI-400945 and radiotherapy (RT).
  • Evaluated cytotoxicity using cell viability and clonogenic assays.
  • Assessed DNA damage response with γH2AX staining and Western blot analysis of relevant proteins.
  • Examined cell-cycle profiles and centrosomal abnormalities through flow cytometry and γ-tubulin staining.
  • Measured apoptosis via cleaved PARP-1 and caspase-3 expression levels.
  • CFI-400945 treatment significantly reduced cell viability and enhanced the cytotoxic effects of RT.
  • Combined therapy increased γH2AX foci formation and upregulated DNA damage proteins like p-ATM and p-CHK2.
  • Inhibition of PLK4 led to mitotic defects, including centrosome amplification and micronuclei formation.
  • Enhanced G2/M arrest and apoptosis were observed with elevated cleaved PARP-1 and caspase-3 levels.

Abstract

Abstract Background: Polo-like kinase 4 (PLK4), a key regulator of centrosome duplication, has been implicated in cancer progression and therapeutic resistance. Although PLK4 overexpression is frequently observed in various malignancies, its functional contribution to radiotherapy (RT) response in colorectal cancer (CRC) remains poorly understood. Methods: To investigate whether PLK4 inhibition enhances radiosensitivity, CRC cell lines HCT116 (p53 wild-type) and HT29 (p53 mutant) were treated with the selective PLK4 inhibitor CFI-400945, RT or their combination. Cell viability and clonogenic assays were performed to evaluate cytotoxicity. DNA damage responses were assessed by γH2AX immunofluorescence and Western blot analysis of p-ATM, p-CHK2, and DNA-PKcs. Cell-cycle profiles and centrosomal abnormalities were examined by flow cytometry and γ-tubulin staining, respectively. Apoptosis was determined through cleaved PARP-1 and caspase-3 expression levels. Results: CFI-400945 treatment reduced cell viability in a dose- and time-dependent manner and significantly enhanced the cytotoxic effects of RT in both CRC cell lines. Combined treatment markedly increased γH2AX foci formation and upregulated DNA damage response proteins, including p-ATM, p-CHK2, and DNA-PKcs. PLK4 inhibition also induced centrosome amplification, micronuclei formation, and multinucleation, indicating mitotic defects leading to genomic instability. Furthermore, the combination therapy enhanced G2/M arrest and apoptosis, as evidenced by elevated levels of cleaved PARP-1 and caspase-3. Conclusions: PLK4 inhibition sensitizes colorectal cancer cells to radiation by promoting DNA damage accumulation, mitotic catastrophe, and apoptotic cell death. These findings suggest that targeting PLK4 may serve as a potential therapeutic strategy to overcome radioresistance in CRC. Citation Format: Sung Uk Bae, Jeong-Woo Hwang, Hyewon Lee, Hyowon Hong, Sang Jun Byun. Inhibition of PLK4 overcomes radioresistance in locally advanced rectal cancer through genomic instability and apoptotic cell death abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6619.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bae et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd13a79560c99a0a2f2dhttps://doi.org/10.1158/1538-7445.am2026-6619
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 6393: Polo-like kinase 4 inhibition enhances radiosensitivity in non-small cell lung cancer via apoptosis and epithelial-mesenchymal transition regulation.2026
  2. 2PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer2024 · 15 citations
  3. 3CFI-400945 enhances radiosensitivity in colorectal cancer models by promoting mitotic dysregulation and DNA damage-associated apoptosis2026
  4. 4Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance2026
  5. 5Abstract 5859: PLK1 predicts aggressive behavior in CRC patients and its inhibition reverse chemoresistance in CRC cells2024